Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-30

Clinical Trial Update: Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety and efficacy of the Measles, Mumps, and Rubella vaccine in patients with juvenile idiopathic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Measles, Mumps, and Rubella vaccine (Measles, Mumps, and Rubella vaccine)

Snippet

Sponsor: N.M. Wulffraat | Conditions: Arthritis, Juvenile Rheumatoid | Phase 4 | Status: COMPLETED